FIELD: medicine.
SUBSTANCE: invention represents a method for qualitative determination of an adaptability to prosthetic bridges based on the oral fluid biomarkers content in a patient with dentofacial new growths; if the oral fluid contents of tissue inhibitor of metalloproteinase 1 (TIMP 1) in an amount of 118.9-145.7 ng/ml and tissue inhibitor of metalloproteinase 2 (TIMP 2) in an amount of 42.4-56.9 ng/ml are detected, the low adaptability of the patient with dentofacial new growths to prosthetic bridges is diagnosed, whereas the oral fluid contents of TIMP 1 in an amount of 68.2-77.4 ng/ml and TIMP 2 in an amount of 21.9-37.7 ng/ml show the complete functional adaptation of the patient with dentofacial new growths to prosthetic bridges.
EFFECT: more accurate determination of the adaptability and more sensitive differential diagnosis of the adaptability.
3 cl, 6 ex
